Search PubMed⌕ Search

Biomedical subjects

G Soubrane

Publications and source records attributed to G Soubrane.

At least 19 recordsLinked to original sources

Analysis of retinal flecks in fundus flavimaculatus using optical coherence tomography.

BACKGROUND/AIM: Retinal flecks are commonly observed in both Stargardt disease and fundus flavimaculatus (FFM). The aim was to determine the precise localisation of these flecks within the retinal layers using Stratus optical coherence tomography (OCT). METHODS: A prospective observational case series. A complete ophthalmological examination, including autofluorescence, fluorescein angiography (FA), and Stratus OCT (Carl Zeiss) was performed in 49 eyes of 26 consecutive patients with FFM. Six to 12 Stratus OCT linear scans focused on the retinal flecks were performed in each eye. RESULTS: The age at presentation ranged from 23 years to 71 years and visual acuity ranged from 20/20 to 20/400. Hyper-reflective deposits classified into two types were observed on Stratus OCT: type 1 lesions (94% of eyes) presented as dome-shaped deposits located in the inner part of the retinal pigment epithelium (RPE) layer and type 2 lesions (86% of eyes) presented as small linear deposits located at the level of the outer nuclear layer and clearly separated from the RPE layer. CONCLUSIONS: Stratus OCT is a non-invasive instrument that provides new information on the location of flecks in FFM. The location of type 2 lesions is quite unusual among macular dystrophies; OCT may therefore be useful in the diagnosis of retinal flecks in some cases of FFM.

Adult↗

Krypton laser photocoagulation induces retinal vascular remodeling rather than choroidal neovascularization.

The purpose of this study is to analyze the retina and choroid response following krypton laser photocoagulation. Ninety-two C57BL6/Sev129 and 32 C57BL/6J, 5-6-week-old mice received one single krypton (630 nm) laser lesion: 50 microm, 0.05 s, 400 mW. On the following day, every day thereafter for 1 week and every 2-3 days for the following 3 weeks, serial sections throughout the lesion were systematically collected and studied. Immunohistology using specific markers or antibodies for glial fibrillary acidic protein (GFAP) (astrocytes, glia and Muller's cells), von Willebrand (vW) (vascular endothelial cells), TUNEL (cells undergoing caspase dependent apoptosis), PCNA (proliferating cell nuclear antigen) p36, CD4 and F4/80 (infiltrating inflammatory and T cells), DAPI (cell nuclei) and routine histology were carried out. Laser confocal microscopy was also performed on flat mounts. Temporal and spatial observations of the created photocoagulation lesions demonstrate that, after a few hours, activated glial cells within the retinal path of the laser beam express GFAP. After 48 h, GFAP-positive staining was also detected within the choroid lesion center. "Movement" of this GFAP-positive expression towards the lasered choroid was preceded by a well-demarcated and localized apoptosis of the retina outer nuclear layer cells within the laser beam path. Later, death of retinal outer nuclear cells and layer thinning at this site was followed by evagination of the inner nuclear retinal layer. Funneling of the entire inner nuclear and the thinned outer nuclear layers into the choroid lesion center was accompanied by "dragging" of the retinal capillaries. Thus, from days 10 to 14 after krypton laser photocoagulation onward, well-formed blood capillaries (of retinal origin) were observed within the lesion. Only a few of the vW-positive capillary endothelial cells stained also for PCNA p36. In the choroid, dilatation of the vascular bed occurred at the vicinity of the photocoagulation site and around it. Confocal microscopy demonstrates that the vessels throughout the path lesion are located within the neuroretina while in the choroid (after separation of the neural retina) only GFAP-positive but no lectin-positive cells can be seen. The involvement of infiltrating inflammatory cells in these remodeling and healing processes remained minimal throughout the study period. During the 4 weeks following krypton laser photocoagulation in the mouse eye, processes of wound healing and remodeling appear to be driven by cells (and vessels) originating from the retina.

Animals↗

[How to perform intravitreal injections].

Drugs to treat retinal diseases are often injected intravitreally. This procedure can cause severe complications. We present ways to minimize the risk for complications. Rigorous preoperative antisepsis with povidone iodine, a sterile environment (using gloves and a mask for the injector, a lid speculum, and a drape on the eye to be injected), and immediate follow-up after injection are key issues of the injection technique.

Humans↗

[Fundus flavimaculatus and choroidal neovascularization].

OBJECTIVE: Fundus flavimaculatus is an aspect of Stargardt disease, which is characterized by juvenile onset, rapidly progressive deterioration, and poor visual outcome due to atrophic areas or flecks. Recently, a late-onset form has been described, on the borderline with AMD. However, choroidal neovascular complications are not frequent and rarely described in Stargardt's disease. CASE REPORT: Late discovery of FFM in a patient over 50 years old. During her follow-up, she presented a decrease in visual acuity due to juxtafoveal choroidal neovascularization. In spite of laser treatment, a retrofoveal recurrence appeared, which was treated with perifoveal laser. DISCUSSION: Confusion between AMD and a late-onset Stargardt may occur because of their many clinical similarities. The population and the fundus results can be similar to AMD and an examiner may be confused. In the literature, choroidal neovascular complications appear in patients over 50 years of age who may suffer from AMD. In fundus flavimaculatus, pigmentary epithelium alterations are due to progressive lipoproteic scrap storage that predisposes to Bruch's membrane rupture and choroidal neovascularization. This physiopathology resembles the that of AMD. CONCLUSION: Choroidal neovascular complications are possible in late-onset Stargardt disease. Their appearance together may be greater than previously believed.

Choroidal Neovascularization↗

[Clinical case of management with intravitreal injection of Ranibizumab (Lucentis) on AMD predominant occult CNV: 6-month follow-up with FA, ICG-A, and OCT].

INTRODUCTION: Controlled clinical trial results of occult choroidal neovascularization (CNV) management in age-related macular degeneration (AMD) using intravitreal injections of Ranibizumab have shown significant improvement in vision for the treated group. CASE REPORT: The first clinical case of minimally classic CNV is reported here with the results at 6 months, not only with changes in visual acuity but also with complete imaging at each follow-up with fluorescein angiography, infracyanine angiography using the scanning laser ophthalmoscope (SLO) and with OCT examination. After the second injection, the patient experienced improvement in vision and complete regression of all symptoms to date (5 months after the first injection), showing very favorable progression during the entire follow-up. CONCLUSION: This clinical case shows extremely favorable progression of the minimally classic lesion resulting from the first two injections of Lucentis. The situation is now stabilized in terms of function and morphology, as shown by the fluorescein and infracyanine SLO angiography and OCT examination.

Aged↗

[SPA-1: semiology for phenotyping AMD: precursors].

PURPOSE: A reliable classification of AMD subgroups is necessary prior to any genetic or clinical investigation. For this purpose, we evaluated a selected list of items for AMD based on color photographs of the fundus but also on fluorescein and ICG angiographies and OCT. The first step (SPA-1) is to evaluate the interobserver agreement for AMD precursors. METHODS: The 30 items for AMD precursors, choroidal neovascularization and atrophy, were chosen from the literature. We selected 20 eyes from 20 consecutive patients affected by various forms of these precursors from the prospective NAT-2 study. Grading was based on color photographs of fundus, red-free frames, and fluorescein angiography. For each eye, five grids were filled in by four independent, experienced readers from our reading center and one expert. Within-subject variance was studied. RESULTS: Within subject variance showed the greatest agreement between graders for drusenoid pigment epithelial detachment (variance=0.000). The worst value for within subject variance (0.255) was recorded for the item "intermediate drusen between 5 and 20." CONCLUSION: This evaluation of our first grid for AMD precursors shows high agreement between graders for most of the items. The item with the lowest agreement should be modified according to the comments of the physicians. This grid could be implemented for phenotypic classification of ARM and AMD in future clinical or genetic studies.

Feasibility Studies↗

[Surgical treatment of persistent macular edema in retinal vein occlusion].

INTRODUCTION: Persistent macular edema (ME) is the main cause of poor visual outcome in nonischemic retinal vein occlusion (RVO). The aim of this study was to evaluate the results of surgery in this disorder. PATIENTS AND METHODS: Retrospective nonrandomized comparative pilot study. Visual acuity measurement, fluorescein angiography, and optical coherence tomography were performed before and after treatment, at 3 months, 6 months, and 1 year. RESULTS: The study included 42 eyes: 15 eyes underwent vitrectomy with peeling of the posterior hyaloid and/or the internal limiting membrane, 19 received intravitreous injection of triamcinolone (IVT), and four had a combination of both treatments. In the vitrectomy group, 63% of the eyes showed a progressive decrease of ME throughout the year of follow-up (p<0.05 at 1 month and 1 year) and an increase in visual acuity (p<0.05 at 3 and 6 months); no complication occurred. In the IVT group, the eyes showed a rapid improvement in vision and in ME at 1 month (p=0.007 and p=0.001, respectively) but with a frequent ME recurrence at 4 months; however, 31% of eyes showed durable improvement. Complications after IVT were pseudo-endophthalmitis (one eye), transient hypertony (53%), and a full-thickness macular hole (one eye). In the group treated with vitrectomy combined with IVT, ME decreased rapidly and durably, but vision did not improve in this small subgroup of long-lasting RVO with prior pigment epithelial changes. CONCLUSION: In some eyes, vitrectomy seems to have a more durable effect than IVT alone. Further randomized and controlled studies are needed to confirm these results and to compare them to the natural course of the disease.

Adult↗

[Comparison of macular limited translocation and photodynamic therapy for management of choroidal neovascularization in degenerative myopia: a retrospective study].

PURPOSE: To analyze the results of limited macular translocation (MT) and photodynamic therapy (PDT) in subfoveal choroidal neovascularization due to degenerative myopia, with a minimum follow-up of 12 months. METHODS: Retrospective review of 55 consecutive patients: 31 eyes were treated using PDT and 24 were operated on with the limited macular translocation technique with chorioscleral infolding described by de Juan. Before and after each treatment, a complete examination comprised visual acuity, fundus examination, fluorescein angiography, and optical coherence tomography. Mean follow-up was 14 months in the PDT group and 19 months in the MT group. RESULTS: The improvement in visual acuity was better in the MT group than in the PDT group and was correlated with younger age (p<0.001). At month 12, visual acuity improved by 3 ETDRS lines or more in 6 six eyes of the PDT group (19%), with no improvement over 6 lines. In the MT group, visual acuity improved by 3 lines in 14 eyes (58%) including 8 eight eyes (33%) with an improvement of 6 lines or more. Final visual acuity remain unchanged (+/-2 lines) in 16 eyes of the PDT group (66%) and 8 eight eyes of the MT group (33%), and decreased in 9 nine eyes in the PDT group (29%) versus 2 two eyes in the MT group (8%). Mean gain in visual acuity at 12 months was +3.5 ETDRS lines in the MT group and -0.1 line in the PDT group (p=0.001). The mean displacement of the fovea after translocation was 950 microm. The mMean number of PDT treatments was 2.3 during the 12-month follow-up. CONCLUSIONS: Limited macular translocation allowed provided a significant improvement in visual acuity in some eyes with subfoveal neovascularization in myopia, especially in young patients, and resulted in a moderate rate of complications. Longer follow-up and further controlled and randomized studies are required to confirm these encouraging findings.

Adult↗

[Macular fold following retinal detachment surgery].

INTRODUCTION: The occurrence of a retinal fold after vitrectomy for retinal reattachment is not often described. In this case report, its treatment, prevention, and mechanism are discussed. CASE REPORT: A 45-year-old pseudophakic woman experienced a superotemporal retinal detachment with macula-on and numerous retinal tears. The treatment consisted of a vitrectomy, perfluorocarbon injection, cryotherapy, and a complete fluid/gas exchange. Postoperative examination disclosed a retinal fold centered by the fovea. The treatment of this macular fold included the creation of a new detachment of the posterior pole by means of an injection of balanced saline solution into the subretinal space through a 39-gauge cannula, the injection of perfluorocarbon liquid to move the fold superiorly, endolaser at the inferior limit of the fold, and silicone oil injection. At the postoperative examination, the macula was flattened and the fold was near the superior temporal arcade. DISCUSSION: The formation of a macular fold after vitrectomy was probably caused by the complete fluid/gas exchange, which displaced the subretinal fluid from the periphery to the posterior pole, detaching the macula. Tangential traction exerted by the presence of intravitreal gas and subretinal fluid might have stretched the retina and resulted in the formation of the fold. This mechanism is similar to the technique used in macular translocation surgery. To avoid this complication in macula-on retinal detachment, we suggest not using perfluorocarbon liquid systematically and replacing the complete fluid/gas exchange with a limited bubble of expansive gas combined with postoperative positioning.

Female↗

[Choroidal white dots and sarcoidosis].

INTRODUCTION: Sarcoidosis is a multisystemic disease characterized by a noncaseating granuloma. Posterior segment disease with white choroidal dots occurs in only 5% of sarcoidosis cases with ocular involvement. OBSERVATION: We report here the case of a 45-year-old Caucasian patient complaining of a skin rash. The biomicroscopic examination of the posterior poles revealed bilateral choroidal white dots with kidney insufficiency. A kidney and skin biopsy revealed the diagnosis of sarcoidosis. CONCLUSION: This case is a rare example of posterior segment manifestation in sarcoidosis that must be considered when observing white choroidal dots.

Choroid Diseases↗

Indocyanine green angiography features of Malattia leventinese.

BACKGROUND/AIM: Malattia leventinese (ML) is an inherited macular degeneration characterised by the presence of small radial drusen. Despite extensive descriptions of this study of the fundus, angiographic features of ML have been inadequately described. The aim is to describe the indocyanine green angiography (ICG) features observed in ML. METHODS: 10 eyes from five consecutive ML patients (aged 27-44 years) were prospectively included. A complete ophthalmological examination including colour fundus photographs, autofluorescence, fluorescein angiography (FA), and ICG was performed. RESULTS: ICG differentiated two types of drusen. Large round aggregated drusen were consistently hypofluorescent in the early phases and presented as hyperfluorescent spots surrounded by halos of hypofluorescence in the late phases. Conversely, small radial drusen were mostly hyperfluorescent in the early phases with decreased fluorescence in the late phases of the ICG sequence. FA also showed differences in staining between the two types of drusen. CONCLUSIONS: ICG angiography revealed marked differences between the large round and small radial drusen observed in ML. The large central drusen presented with an unusual pustuliform feature on the late phases of the ICG sequence. This distinct feature may be useful in the diagnosis of late stage disease when drusen consolidation could obscure the radial drusen.

Adult↗

Evolving European guidance on the medical management of neovascular age related macular degeneration.

BACKGROUND: Until recently, only two options were available for the treatment of choroidal neovascularisation (CNV) associated with age related macular degeneration (AMD)-thermal laser photocoagulation and photodynamic therapy with verteporfin (PDT-V). However, new treatments for CNV are in development, and data from phase III clinical trials of some of these pharmacological interventions are now available. In light of these new data, expert guidance is required to enable retina specialists with expertise in the management of AMD to select and use the most appropriate therapies for the treatment of neovascular AMD. METHODS: Consensus from a round table of European retina specialists was obtained based on best available scientific data. Data rated at evidence levels 1 and 2 were evaluated for laser photocoagulation, PDT-V, pegaptanib sodium, and ranibizumab. Other treatments discussed are anecortave acetate, triamcinolone acetonide, bevacizumab, rostaporfin (SnET2), squalamine, and transpupillary thermotherapy. RESULTS: PDT-V is currently recommended for subfoveal lesions with predominantly classic CNV, or with occult with no classic CNV with evidence of recent disease progression and a lesion size <or=4 Macular Photocoagulation Study (MPS) disc areas (DA). The new classes of anti-angiogenic agents-namely, pegaptanib sodium and ranibizumab (the latter when peer reviewed phase III data become available) are recommended for subfoveal lesions with any proportion of classic CNV or occult with no classic CNV. For juxtafoveal classic CNV, PDT-V or anti-angiogenic therapy should be considered if the new vessels are so close to the fovea that laser photocoagulation would almost certainly extend under the centre of the foveal avascular zone. For all other well demarcated juxtafoveal lesions and for extrafoveal classic lesions, laser photocoagulation remains the standard treatment. Therapy should be undertaken within 1 week of the fluorescein angiogram on which the clinical decision to treat is based. At each follow up, fluorescein angiography should be performed and best corrected visual acuity measured as a minimum requirement. CONCLUSIONS: These recommendations provide evidence based guidance for the choice and use of non-surgical therapies for the management of neovascular AMD. Revisions of the recommendations may be required as new data become available.

Antibodies, Monoclonal↗

[Indications for photodynamic therapy in age-related macular degeneration].

Exudative age-related macular degeneration (ARMD) is now benefitting from new therapeutic approaches. Three international randomized clinical trials have demonstrated the efficacy of photodynamic therapy (PDT) in stabilizing visual acuity at 2 years. PDT is based on the activation of a photosensitizer with an adapted wavelength. In age-related macular degeneration, the photosensitizer used is verteporfin (Visudyne), which accumulates preferentially in choroidal new vessels. Functional results are obtained on the basis of a strict classification based on fluorescein angiography examining the type of the new vessels responsible for exudative ARMD. Thus, subfoveal lesions, either predominantly classic (>50%) or occult only, are the indication for PDT. Classic CNVs where laser photocoagulation thermal burns extend into the foveola may be an extrapolation of the indication for PDT. In addition, fluorescein angiography is essential for considering retreatment, usually necessary. Demonstrated growth and the persistence of leakage from the CNV is an absolute indication for a new session of PDT. A number of features still require assessment in order to define the responder group more accurately and to refine and possibly simplify the indications for retreatment.

Choroidal Neovascularization↗

[Monitoring the patient after treatment: angiographic aspects of recurrence and indications for retreatment].

OBJECTIVES: Dynamic phototherapy with intravenous injection of Verteporfin (Visudyne) is a relatively recent therapeutic concept based on a photochemical reaction. Its statistically significant efficacy has been demonstrated in treating choroidal newvessels and age-related macular degeneration. This occlusion is often temporary, thus requiring repeated treatments in persistent cases and/or recurrences. Angiographic monitoring of the patient, over the short or medium term and then later over the long term, will identify these cases. METHODS: The indications for retreatment are based on very close follow-up with fluorescein angiographic results, and the persistence or reappearance of leakage should be analyzed and clearly distinguished from staining phenomena. Leakage is an essential element and the main diagnostic criterion of recurrence. Associated criteria could be envisaged based on follow-up angiographic examinations at different stages of progression: early, at 4 or 6 weeks (often a good indicator of progression), or at 3 months, currently indispensable. RESULTS: With a relatively stable lesion with no progression or extension, the angiographic examination will make it possible to decide whether a treatment is needed: either retreatment if there is leakage or no treatment if the lesion is fibrous. To assist in therapeutic decisions, a number of arguments must be gathered based on fluorescein angiography but also on indocyanine green angiography (ICG), which will analyze neovascularization, and optical coherence tomography (OCT) examination, which will bring out the presence or absence of fluid at the lesion, as well as functional signs of visual acuity. In difficult cases, the angiographic examination will determine the source of the major decreases in acuity that can be caused by hemorrhages, breaks (which are not necessarily absolute contraindications for retreatment), or acute choroidal ischemia. CONCLUSIONS: Fluorescein and IGC angiographic follow-up and OCT examinations will screen and analyze persistence or reperfusion of choroidal neovessels as well as the extension or reappearance of lesions and, on the other hand, the presence or absence of fibrotic staining phenomena and scarring. The changes in central visual acuity and different functional signs are indicators of patient management and therapeutic indications.

Angiography↗

Clinical features of drusenoid pigment epithelial detachment in age related macular degeneration.

AIM: To analyse clinical features of drusenoid pigment epithelium detachment (PED) in age related macular degeneration. METHODS: 61 eyes of 32 patients with untreated drusenoid PED were followed for an average of 4.6 years (range 1-17 years). Drusenoid PED was defined as (1/2) disc diameter (DD) of confluent soft drusen under the centre of the macula. All patients underwent visual acuity measurement, biomicroscopic fundus examination, stereoscopic colour photograph, and fluorescein and indocyanine green angiography. Optical coherence tomography was performed in selected cases at the last examination. Kaplan Meier survival analysis was performed to estimate the probability of complications. RESULTS: Three different natural outcomes were identified: persistence of drusenoid PED (38%), development of geographic atrophy (49%), and choroidal neovascularisation (CNV) (13%). Based on Kaplan Meier survival analysis, drusenoid PED had a 50% of chance of developing geographic atrophy after 7 years. If the drusenoid PED was greater than 2 DD or was associated with metamorphopsia at initial presentation, progression to atrophy or ingrowth of CNV occurred after 2 years (p<0.01). Indocyanine green angiography confirmed fluorescein angiographic features or ascertained the presence of CNV when fluorescein angiography was equivocal. Optical coherence tomography was helpful in distinguishing coalescent soft drusen from drusenoid PED and disclosed the accumulation of sub or intraretinal fluid in eyes with CNV. CONCLUSION: Drusenoid PED size greater than 2 DD and metamorphopsia were risk factors identified at presentation which affected prognosis. The evaluation of the eyes at risk requires the use of all imaging means in order to ascertain the diagnosis of CNV. At long term (over 10 years), geographic atrophy and CNV had occurred in 75% and 25% respectively, with a poor visual outcome.

Aged↗

[Optical coherence tomography and ARMD].

Optical coherent tomography examination (OCT) is a new medical diagnostic imaging modality analogous to ultrasound B-mode imaging, able to perform anteroposterior cross-sectional imaging of interior tissues and is useful in clinical practice in ARMD. The combination of fluorescein and ICG angiography imaging with OCT imaging will bring additional information for all clinical forms of ARMD. Many patterns and images are easy to identify, including serous retinal detachment, diffuse or cystoid retinal edema, serous or fibrovascular retinal pigment epithelium detachment with or without retinal pigment epithelium (RPE) tears and fibrosis. Other symptoms are more difficult to detect and to analyze and will need to be combined with other imaging techniques: the presence of choroidal new vessels and their localisation related to the center of the fovea and the RPE; the association of different lesions (hemorrhages, exudation, fibrosis, anastomosis and PE detachment) and recognition of less frequent lesions such as polypoidal choroidal vasculopathy. During follow-up, choroidal new vessels may be shown with different modalities. OCT examination could detect and localize these lesions, helping to determine the best management strategy. OCT examination appears to be particularly useful for both detection of persistent fluid and reabsorption and reattachment of the retina.

Aged↗

[Results of limited macular translocation in subfoveal choroidal neovascularization in age-related macular degeneration].

PURPOSE: Age-related macular degeneration (AMD) is the major cause of legal blindness in industrialized countries. The exudative form could be responsible for severe visual loss. Recent therapeutic approaches are now available for treating subfoveal neovascularization. The purpose of this study was to evaluate the visual results obtained with macular translocation (MT) in subfoveal choroidal neovascularization due to AMD. METHODS: A prospective nonrandomized review of 29 consecutive patients with subfoveal neovascularization attributable to AMD. Limited macular translocation with chorioscleral infolding based on the De Juan technique was performed. The mean follow-up was 14 months. RESULTS: The mean age of the patients studied was 75 years. The mean initial visual acuity was 20/200, with of 59% of patients having worse than 20/200. The mean displacement of the fovea after translocation was 1,274 microm, and at 1 year, vision was grossly unchanged in comparison to baseline (mean final gain of 0.7 line). Postoperative complications observed were retinal detachment (17.2%), macular hole (13%) and macular fold (14%). No complication was seen in 55.2% of the operated eyes, which had a mean final gain of 3.25 ETDRS lines at 14 months of follow-up. In comparison to the photodynamic therapy (PDT) group of the TAP study, 48% of the MT group had a gain of 1 line or more versus 16% of the PDT group. CONCLUSION: MT may lead to a significant improvement in visual acuity. Further larger and controlled studies are required to evaluate MT in the treatment of subfoveal neovascularization.

Aged↗

[Retinal vein occlusion and hyperhomocysteinemia].

INTRODUCTION: Previous studies have reported that an elevated plasma homocysteine level is a risk factor for vascular disease. The aim of this study is to determine whether hyperhomocysteinemia is a risk factor for retinal vein occlusion (RVO) and whether it is a prognostic factor. PATIENTS AND METHODS: The plasma homocysteine level was measured in 101 patients and compared to the plasma homocysteine level of controls. The relation between plasma homocysteine level and the other known risk factors of retinal vein occlusion was studied, as well as the correlation between the clinical outcome of the RVO and the plasma homocysteine level. RESULTS: The mean plasma homocysteine level was significantly higher in the 101 RVO patients than in the 29 controls (11.9 mmol/l vs 8.6, p<0.001). We found no relation between plasma homocysteine and other risk factors of vascular disease except for the hematocrit level. Hyperhomocysteinemia was more frequent in the ischemic forms and in bilateral RVO, but the difference was not statistically significant. CONCLUSIONS: Hyperhomocysteinemia seems to be an independent risk factor for RVO and was more frequent in severe RVO, but our study did not evidence an association with a severe prognosis. Vitamin therapy can decrease homocysteinemia but its efficacy in the prevention and in the treatment of RVO remains to be demonstrated.

Adult↗